Evidence map›Paper›PMID 41155097›Full record

ArticleBioengineering (Basel, Switzerland)2025

Disease-Specific Prediction of Missense Variant Pathogenicity with DNA Language Models and Graph Neural Networks.

Mohamed Ghadie, Sameer Sardaar, Yannis Trakadis

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohamed GhadieResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A 3J1, Canada.
Sameer SardaarResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A 3J1, Canada.
Yannis TrakadisResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A 3J1, Canada.ORCID 0000-0002-8740-4416

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate prediction of the impact of genetic variants on human health is of paramount importance to clinical genetics and precision medicine. Recent machine learning (ML) studies have tried to predict variant pathogenicity with different levels of success. However, most missense variants identified on a clinical basis are still classified as variants of uncertain significance (VUS). Our approach allows for the interpretation of a variant for a specific disease and, thus, for the integration of disease-specific domain knowledge. We utilize a comprehensive knowledge graph, with 11 types of interconnected biomedical entities at diverse biomolecular and clinical levels, to classify missense variants from ClinVar. We use BioBERT to generate embeddings of biomedical features for each node in the graph, as well as DNA language models to embed variant features directly from genomic sequence. Next, we train a two-stage architecture consisting of a graph convolutional neural network to encode biological relationships. A neural network is then used as the classifier to predict disease-specific pathogenicity of variants, essentially predicting edges between variant and disease nodes. We compare performance across different versions of our model, obtaining prediction-balanced accuracies as high as 85.6% (sensitivity: 90.5%; NPV: 89.8%) and discuss how our work can inform future studies in this area.

Indexed as

ClinVardisease-specific variant interpretationgenetic variant pathogenicity predictiongenomic embeddingsgraph convolutional neural network (GCN)machine learning (ML)missense variantsneural network classifiervariants of uncertain significance (VUS)

Identifiers

PMID41155097
PMCPMC12562010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.